Journal
PLOS ONE
Volume 6, Issue 2, Pages -Publisher
PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0014665
Keywords
-
Categories
Funding
- Swiss Cancer League [KPS-OCS 01812-12-2005]
- Swiss National Science Foundation [FNS-310030-120184]
- GenKyoTex S.A.
- Swiss National Science Foundation (SNF) [310030-120184] Funding Source: Swiss National Science Foundation (SNF)
Ask authors/readers for more resources
Reactive oxygen species, ROS, are regulators of endothelial cell migration, proliferation and survival, events critically involved in angiogenesis. Different isoforms of ROS-generating NOX enzymes are expressed in the vasculature and provide distinct signaling cues through differential localization and activation. We show that mice deficient in NOX1, but not NOX2 or NOX4, have impaired angiogenesis. NOX1 expression and activity is increased in primary mouse and human endothelial cells upon angiogenic stimulation. NOX1 silencing decreases endothelial cell migration and tube-like structure formation, through the inhibition of PPAR alpha, a regulator of NF-kappa B. Administration of a novel NOX-specific inhibitor reduced angiogenesis and tumor growth in vivo in a PPAR alpha dependent manner. In conclusion, vascular NOX1 is a critical mediator of angiogenesis and an attractive target for anti-angiogenic therapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available